NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine

Via Scoop.itVirology News

ROCKVILLE, Md. — Novavax, Inc. today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate. This randomized, …


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: